부스트이뮨은 면역 시스템 조절을 통해 암을 치료할 수 있는 first-in-class 혁신 신약을 개발하는 바이오 기업입니다.
Location: South Korea, Seoul
Investors 5
| Date | Name | Website |
| - | SV Investm... | svinvest.c... |
| - | AJU IB Inv... | ajuib.co.k... |
| - | we venture... | en.weventu... |
| 18.12.2025 | Company K ... | kpartners.... |
| 20.06.2023 | Premier Pa... | premierpar... |
Mentions in press and media 1
| Date | Title | Description |
| 13.07.2026 | Boostimmune Secures Japanese Patent for Sequence-Independent TCTP Antibody Technology Targeting MDSC Accumulation | Japanese patent granted for technology that inhibits TCTP released from dead tumor cells using antibodies to suppress the accumulation of MDSCs in the tumor microenvironment Granted claims are not expressly limited to specific antibody CDRs... |